Clinicohematological profile and immunophenotypic patterns of childhood acute leukemia: Prognostic correlation
Tumor Discovery · 2024
DOI: 10.36922/td.2545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tumor Discovery, 2024. Verfasst von Anju Khairwa und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Acute leukemia (AL) presents a heterogeneous molecular profile, requiring precise diagnostic categorization and subcategorization. The present study aims to estimate the clinicohematological profile and immunophenotypic pattern of childhood AL while conducting prognostic assessments. This cross-sectional study analyzed a total of 68 samples of AL collected from January 2019 to June 2021. The male-to-female ratio was 4.6:1, with a mean age of 6.6 ± 3.4 years. Total leukocyte count (TLC) was significantly increased in all types of AL (P = 0.03). The median value (interquartile range) of TLC (×106/dL) was 8,450 (4,100 – 27,950), with blast counts in peripheral smears at 59 (24 – 80), and in bone marrow aspirates (BMAs) at 95 (75 – 98). There was a significant association (P < 0.001) and a strong association (C = 0.9110) between the morphology of BMA with immunophenotype. Based on immunophenotype, AL was categorized into four groups: B-cell acute lymphoblastic leukemia (B-ALL) (51.5%), T-cell acute lymphoblastic leukemia (T-ALL) (10.3%), AML (22%), and mixed phenotype AL (MPAL) (16.2%). Furthermore, eight subgroups were identified: B lineage, Ia-Common-B-ALL (88.6%) and Ib-Pre-B-ALL (11.4%); T-lineage, IIa-Cortical T-ALL (71.4%) and IIb-Pre-T-ALL (28.6%); AML subgroups, IIIa-M2 (73.93%) and III-M4 (26.7%); and MPAL subgroups, IVa-aberrant expression of myeloid antigens in B-ALL (90.9%), and IVb-aberrant expression of lymphoid markers in AML (9.1%). A poor prognostic immunophenotype (T-ALL, AML) was significantly (P = 0.023) more prevalent in deceased patients with AL. The highest mortality rate was observed in AML (86.4%), followed by T-ALL (57.2%). The most common immunophenotype observed was Common-B-ALL in childhood AL, and a poor prognostic immunophenotype (T-ALL and AML) with the highest mortality rate was found in AML. Thus, knowledge about clinicohematological and immunophenotypic patterns will aid in patient management.
Zitieren
APA
Khairwa, A., Kotru, M., Dewan, P., & Jain, S. (2024). Clinicohematological profile and immunophenotypic patterns of childhood acute leukemia: Prognostic correlation. Tumor Discovery. https://doi.org/10.36922/td.2545
Vancouver
Khairwa A, Kotru M, Dewan P, Jain S. Clinicohematological profile and immunophenotypic patterns of childhood acute leukemia: Prognostic correlation. Tumor Discovery. 2024. doi:10.36922/td.2545
BibTeX
@article{Khairwa2024,
author = {Khairwa, Anju and Kotru, Mrinalini and Dewan, Pooja and Jain, Swati},
title = {Clinicohematological profile and immunophenotypic patterns of childhood acute leukemia: Prognostic correlation},
journal = {Tumor Discovery},
year = {2024},
doi = {10.36922/td.2545}
}
EUVIMED